Showing 1 - 10 of 4,918
Apinya Wipatayotin, Published on 16/06/2024
» The KP.2 strain of Covid-19 will become dominant in Thailand, according to a renowned virologist. It will be more transmissible and vaccines will be hard-pressed to keep up with its mutations, but its symptoms will not be more severe that those of previous strains of the virus.
Published on 12/06/2024
» The Asian Institute of Technology (AIT) has awarded Asian Development Bank (ADB) President Masatsugu Asakawa an Honorary Doctor of Philosophy degree in recognition of his exceptional contributions to the economic, social, and technological advancement of Asia and the Pacific.
Apinya Wipatayotin, Published on 10/06/2024
» Covid-19 cases last week jumped by at least 900 on the previous week, with one fatality recorded each day, the Public Relations Department’s Covid-19 Information Centre revealed.
News, Apinya Wipatayotin, Published on 05/06/2024
» Most people do not need to get a booster against the latest strain of Covid-19, except for vulnerable groups and the unvaccinated, as the symptoms are relatively mild and the vaccine must be paid for, according to virologist Yong Poovorawan.
Oped, Published on 04/06/2024
» On Dec 12, 2019, a group of patients in Wuhan, China, started showing symptoms of an atypical pneumonia-like illness that did not respond well to standard treatments. Ninety days later, with more than 118,000 cases reported in 114 countries and 4,291 deaths, the World Health Organization (WHO) declared Covid-19 a pandemic.
Published on 26/05/2024
» Experts say antiviral therapeutics need to be an investment priority if another pandemic were to happen in the future, due to the possible length of time a vaccine takes to develop.
News, Onnucha Hutasingh, Published on 17/05/2024
» Mahidol University has inched closer to starting the world's first clinical trial of an mRNA vaccine against malaria.
Oped, Postbag, Published on 11/05/2024
» Re: "A rice old business", (Editorial, May 10).
Published on 08/05/2024
» The pharmaceutical company AstraZeneca says it has initiated the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.
News, Apinya Wipatayotin, Published on 04/05/2024
» Only seven out of more than 20 million people have been reported as suffering blood clots after receiving the AstraZeneca Covid-19 vaccine, the National Vaccine Institute on Friday revealed, insisting that the chances of developing the condition are very low.